Daniel Offen
Daniel Offen
Verified email at post.tau.ac.il
TitleCited byYear
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier
Y Gilgun-Sherki, E Melamed, D Offen
Neuropharmacology 40 (8), 959-975, 2001
7662001
Antioxidant therapy in acute central nervous system injury: current state
Y Gilgun-Sherki, Z Rosenbaum, E Melamed, D Offen
Pharmacological reviews 54 (2), 271-284, 2002
6012002
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy
Y Gilgun-Sherki, E Melamed, D Offen
Journal of neurology 251 (3), 261-268, 2004
5872004
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease
M Vila, V Jackson-Lewis, S Vukosavic, R Djaldetti, G Liberatore, D Offen, ...
Proceedings of the National Academy of Sciences 98 (5), 2837-2842, 2001
3582001
Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel pathogenetic mechanism in Parkinson's disease
I Ziv, E Melamed, N Nardi, D Luria, A Achiron, D Offen, A Barzilai
Neuroscience letters 170 (1), 136-140, 1994
2891994
Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease
D Offen, I Ziv, H Sternin, E Melamed, A Hochman
Experimental neurology 141 (1), 32-39, 1996
2841996
Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice
E Hochhauser, S Kivity, D Offen, N Maulik, H Otani, Y Barhum, H Pannet, ...
American Journal of Physiology-Heart and Circulatory Physiology 284 (6 …, 2003
2632003
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity
D Offen, PM Beart, NS Cheung, CJ Pascoe, A Hochman, S Gorodin, ...
Proceedings of the National Academy of Sciences 95 (10), 5789-5794, 1998
2481998
The “dying-back” phenomenon of motor neurons in ALS
M Dadon-Nachum, E Melamed, D Offen
Journal of Molecular Neuroscience 43 (3), 470-477, 2011
2182011
Human mesenchymal stem cells express neural genes, suggesting a neural predisposition
NR Blondheim, YS Levy, T Ben-Zur, A Burshtein, T Cherlow, I Kan, ...
Stem cells and development 15 (2), 141-164, 2006
1792006
Apoptosis and Parkinson's disease
N Lev, E Melamed, D Offen
Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (2), 245-250, 2003
1702003
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease
D Offen, Y Sherki, E Melamed, M Fridkin, DE Brenneman, I Gozes
Brain research 854 (1-2), 257-262, 2000
1662000
Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents
MA Hellmann, H Panet, Y Barhum, E Melamed, D Offen
Neuroscience letters 395 (2), 124-128, 2006
1552006
Enhanced Oxidative Stress and Altered Antioxidants in Brains of Bcl‐2‐Deficient Mice
A Hochman, H Sternin, S Gorodin, S Korsmeyer, I Ziv, E Melamed, ...
Journal of neurochemistry 71 (2), 741-748, 1998
1551998
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease
YS Levy, M Bahat-Stroomza, YS Levy, M Bahat-Stroomza, R Barzilay, ...
Cytotherapy 10 (4), 340-352, 2008
1402008
Protective effects of neurotrophic factor–secreting cells in a 6-OHDA rat model of Parkinson disease
O Sadan, M Bahat-Stromza, Y Barhum, YS Levy, A Pisnevsky, H Peretz, ...
Stem cells and development 18 (8), 1179-1190, 2009
1392009
Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-κB via Ref-1
D Daily, A Vlamis-Gardikas, D Offen, L Mittelman, E Melamed, ...
Journal of Biological Chemistry 276 (2), 1335-1344, 2001
1392001
Dopamine-induced programmed cell death in mouse thymocytes
D Offen, I Ziv, S Gorodin, A Barzilai, Z Malik, E Melamed
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1268 (2), 171-177, 1995
1371995
Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection
N Lev, D Ickowicz, E Melamed, D Offen
Neurotoxicology 29 (3), 397-405, 2008
1332008
Antioxidant treatment in Alzheimer’s disease
Y Gilgun-Sherki, E Melamed, D Offen
Journal of Molecular Neuroscience 21 (1), 1-11, 2003
1222003
The system can't perform the operation now. Try again later.
Articles 1–20